SUPRIYA
NSESupriya Lifescience Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹977.15
40.15 (4.28%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹7.86K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
36.1
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹545.5+79.1%
52W High₹1,085-9.9%
Current Price
₹977.15
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹781.72
Upper Circuit₹1,172.58
Reference Price
₹977.15
Investment Checklist
Inverse Head and Shoulders on 1W (BREAKOUT CONFIRMED) — target ₹881.9
Double Bottom on 1W (BREAKOUT CONFIRMED) — target ₹963.55
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bullish (price down, volume up)
Composite score 36.37 (BUY) with 83.8% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
84%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
875.63
EMA50
779.87
EMA200
713.38
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows4
Lower Highs4
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹1085.00
Support (Below)
₹832.40
₹823.25
₹768.50
₹751.73
₹735.35
Volume Analysis
TrendINCREASING
Change+36.20%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹967.38
3% Risk₹947.84
5% Risk₹928.29
7% Risk (Custom)
₹908.75Technical Levels
1x ATR (Volatility)₹923.61
2x ATR (Swing)₹870.07
3x ATR (Trend)₹816.53
Immediate Support₹832.40
Moving Averages
EMA 9 (Short-term)₹935.55
EMA 20 (Medium-term)₹875.63
EMA 50 (Trend)₹779.87
EMA 200 (Long-term)₹713.38
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹167.2 Cr | ₹145.1 Cr | ₹199.8 Cr | ₹206.4 Cr |
| Net Profit | ₹50.4 Cr | ₹34.8 Cr | ₹50.4 Cr | ₹49.7 Cr |
| EPS | — | ₹4.32 | ₹6.27 | ₹6.17 |
| Operating Profit | ₹69.4 Cr | ₹54.4 Cr | ₹75.4 Cr | ₹74.2 Cr |
ROE
18.86%
ROCE
24.84%
Debt/Equity
0.01
Current Ratio
5.32
OPM
35.96%
NPM
24.06%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 04 Sept 2025 | Dividend - Re 1 Per Share | DIVIDEND |
| 20 Sept 2024 | Annual General Meeting/Dividend - Rs 0.80 Per Share | AGM |
| 15 Sept 2023 | Annual General Meeting/Dividend - Re 0.60 Per Share | AGM |
| 01 Sept 2022 | Annual General Meeting/Dividend - Re 0.60 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SUPRIYA
View AllNEWS
negative
Business Standard - Markets 11d ago
Supriya Lifescience Ltd leads losers in 'A' group
Wockhardt Ltd, NHPC Ltd, Force Motors Ltd and RHI Magnesita India Ltd are among the other losers in the BSE's 'A' group today, 02 June 2026.
BSEFORCEMOTNHPCRHIMSUPRIYAWOCKPHARMAAutomobile and Auto ComponentsCapital Goods
NEWS
neutral
Business Standard - Markets 15d ago
Supriya Lifescience Ltd leads gainers in 'A' group
Relaxo Footwears Ltd, Wockhardt Ltd, Netweb Technologies India Ltd and Ashapura Minechem Ltd are among the other gainers in the BSE's 'A' group today, 29 May 2026.
ASHAPURMINBSENETWEBRELAXOSUPRIYAWOCKPHARMAConsumer DurablesFinancial Services
positive
ET Markets - Stocks 15d ago
Supriya Lifescience shares surge 17% on strong Q4 earnings; PAT rises 47% YoY
Supriya Lifescience shares jumped over 16% after the company posted a strong Q4FY26 performance, with PAT rising 47% YoY and revenue surging 50%. Robust demand across therapeutic segments, improved capacity utilisation, and traction in regulated markets supported growth. The stock remains in an uptrend despite overbought technical indicators.
SUPRIYAHealthcare